Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Non-Current Assets (2024 - 2026)

Carlsmed filings provide 2 years of Non-Current Assets readings, the most recent being $3.4 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 39.39% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.4 million, a N/A change, with the full-year FY2025 number at $3.4 million, up 39.39% from a year prior.
  • Non-Current Assets hit $3.4 million in Q4 2025 for Carlsmed, up from $3.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $7.1 million in Q2 2025 to a low of $2.5 million in Q4 2024.